- Report
- October 2024
- 191 Pages
Global
From €3399EUR$3,545USD£2,840GBP
€3776EUR$3,939USD£3,155GBP
- Report
- August 2024
- 175 Pages
Global
From €4793EUR$5,000USD£4,005GBP
- Report
- August 2020
- 111 Pages
Global
From €4074EUR$4,250USD£3,404GBP
The Canine Arthritis Drugs market is a segment of the Animal Pharmaceuticals industry that focuses on providing medications to treat arthritis in dogs. These drugs are typically used to reduce inflammation and pain, as well as to slow the progression of the disease. Commonly used drugs include non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying antirheumatic drugs (DMARDs). In addition, supplements such as glucosamine and chondroitin are often used to help manage the symptoms of arthritis.
The Canine Arthritis Drugs market is highly competitive, with a number of companies offering products to treat the condition. Some of the major players in the market include Zoetis, Elanco, Merck Animal Health, Bayer Animal Health, and Ceva Animal Health. Show Less Read more